![Andreas Calatzis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andreas Calatzis
Amministratore Delegato presso enicor GmbH
Profilo
Andreas Calatzis is the founder of enicor GmbH, which was founded in 2019.
He is currently the Chairman at GlyCardial Diagnostics SL and the Co-Managing Director at Dynabyte - Informationssysteme GmbH.
Posizioni attive di Andreas Calatzis
Società | Posizione | Inizio |
---|---|---|
enicor GmbH
![]() enicor GmbH Medical SpecialtiesHealth Technology enicor GmbH engages development, production, and marketing of medical technology solutions. The firm distributes its products under the ClotPro analyzer, Active Tip Technology, and ClotPro controls brands. It also offers coagulation assays, cups and pins, as well as software solutions. The company was founded by Andreas Calatzis on March 4, 2019 and is headquartered in Munich, Germany. | Amministratore Delegato | 04/03/2019 |
GlyCardial Diagnostics SL
![]() GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017. | Presidente | - |
Dynabyte - Informationssysteme GmbH
![]() Dynabyte - Informationssysteme GmbH Miscellaneous Commercial ServicesCommercial Services Dynabyte - Informationssysteme GmbH is a German company that provides drug, device, company, clinical trial, and market intelligence in the pharmaceutical and medtech markets. The private company is based in Munich, Germany. The company has a team of over 510 specialists who are industry-leading experts in key markets. The company's expertise is trusted in Pharma Intelligence. The company offers extensive coverage of medtech news and insights, trends, and source information on the impact of technologies like diagnostic imaging. The company was founded in 1986, and the CEOs are Andreas Calatzis and Alexander Calatzis. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
enicor GmbH
![]() enicor GmbH Medical SpecialtiesHealth Technology enicor GmbH engages development, production, and marketing of medical technology solutions. The firm distributes its products under the ClotPro analyzer, Active Tip Technology, and ClotPro controls brands. It also offers coagulation assays, cups and pins, as well as software solutions. The company was founded by Andreas Calatzis on March 4, 2019 and is headquartered in Munich, Germany. | Health Technology |
GlyCardial Diagnostics SL
![]() GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017. | Commercial Services |
Dynabyte - Informationssysteme GmbH
![]() Dynabyte - Informationssysteme GmbH Miscellaneous Commercial ServicesCommercial Services Dynabyte - Informationssysteme GmbH is a German company that provides drug, device, company, clinical trial, and market intelligence in the pharmaceutical and medtech markets. The private company is based in Munich, Germany. The company has a team of over 510 specialists who are industry-leading experts in key markets. The company's expertise is trusted in Pharma Intelligence. The company offers extensive coverage of medtech news and insights, trends, and source information on the impact of technologies like diagnostic imaging. The company was founded in 1986, and the CEOs are Andreas Calatzis and Alexander Calatzis. | Commercial Services |
- Borsa valori
- Insiders
- Andreas Calatzis